Management of refractory ascites

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 12, 2005, Pages 1187-1191

  Cárdenas, Andrés ^a,b   Ginès, Pere ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CIPROFLOXACIN; DIURETIC AGENT; FUROSEMIDE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; NORFLOXACIN; PLASMA SUBSTITUTE; PNEUMOCOCCUS VACCINE; QUINOLONE DERIVATIVE; SPIRONOLACTONE;

ASCITES; BACTERIAL PERITONITIS; CLINICAL FEATURE; CLINICAL TRIAL; DIETARY INTAKE; DRUG COST; DRUG EFFECT; DRUG MEGADOSE; FOLLOW UP; HEALTH CARE COST; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HUMAN; HYPERKALEMIA; HYPONATREMIA; INFECTION PREVENTION; INFLUENZA; KIDNEY FAILURE; LIVER TRANSPLANTATION; LOBAR PNEUMONIA; PARACENTESIS; PORTOSYSTEMIC ANASTOMOSIS; PRACTICE GUIDELINE; REVIEW; SODIUM RESTRICTION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 29144453849     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00861-X     Document Type: Article

References (6)

1. V. Arroyo P. Ginès A. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Hepatology 23 1996 164 176
2. P. Ginès A. Cardenas V. Arroyo Management of cirrhosis and ascites N Engl J Med 350 2004 1646 1654
3. T.D. Boyer Z. Haskal The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension Hepatology 41 2005 386 400
4. K. Moore F. Wong P. Ginès The management of ascites in cirrhosis report on the consensus conference of the International Ascites Club Hepatology 38 2003 258 266
5. B. Runyon Management of adult patients with ascites due to cirrhosis Hepatology 39 2004 841 856
6. P.S. Kamath R.H. Weisner M. Malinchoc A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470